clarithromycin has been researched along with cefotaxime in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 9 (32.14) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Arakawa, Y; Kimura, K; Nagano, N; Nagano, Y; Tamai, K; Yanagisawa, H | 1 |
| Iwata, S; Murayama, SY; Nakayama, E; Sakata, H; Seki, C; Sunakawa, K; Sunaoshi, K; Ubukata, K | 1 |
| Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Chiba, N; Ida, T; Kishii, K; Morozumi, M; Ono, A; Ubukata, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Finegold, SM; Wexler, HM | 1 |
| Parent, M | 1 |
| Rodriguez, WJ; Wiedermann, BL | 1 |
| Chick, TW; Neu, HC | 1 |
| Carpentier, M; Delmée, M; Glupczynski, Y; Gordts, B; Magerman, K; Simon, A; Surmont, I; Van de Vyvere, M; Van Landuyt, H; Van Nimmen, L; Van Noyen, R | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| McWhinney, PH; Ragunathan, PL; Rowbottham, TJ | 1 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Chan, PK; Cheng, WT; Chiu, MC; Chu, WC; Fok, TF; Fong, NC; Hon, KL; Kwan, YW; Leung, CW; Li, AM; Li, CK; Ng, PC; Tam, JS | 1 |
| García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A | 1 |
| Ayaz, C; Celen, MK; Geyik, MF; Hosoglu, S; Ozmen, E | 1 |
| Chaturvedi, S; Langlois, V; Licht, C | 1 |
| Al Azemi, M; Al Sweih, N; Bin Nakhi, HA; Joshi, RM; Nair, S | 1 |
| Aebi, C; Bernhard, S; Spaniol, V | 1 |
| Fujii, T; Ito, A; Nakaminami, H; Noguchi, N; Utsumi, K | 1 |
| Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
2 review(s) available for clarithromycin and cefotaxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
1 trial(s) available for clarithromycin and cefotaxime
| Article | Year |
|---|---|
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Topics: Adult; Aged; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; United States | 1993 |
25 other study(ies) available for clarithromycin and cefotaxime
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Female; Genetic Heterogeneity; Humans; Infant, Newborn; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Phylogeny; Sequence Analysis, DNA; Streptococcus agalactiae | 2008 |
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.
Topics: Adolescent; Adult; Aged; Bacterial Capsules; Child; Child, Preschool; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant; Infant, Newborn; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Polymerase Chain Reaction; Streptococcus agalactiae | 2009 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
In vitro activity of tebipenem, a new oral carbapenem antibiotic, against beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae.
Topics: Ampicillin Resistance; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Haemophilus influenzae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2010 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Chloramphenicol; Clarithromycin; Clindamycin; Erythromycin; Microbial Sensitivity Tests | 1987 |
[Initial empiric treatment of pneumonia and the new antibiotics].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefuroxime; Clarithromycin; Fluoroquinolones; Humans; Pneumonia | 1994 |
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefotaxime; Cefuroxime; Child; Child, Preschool; Clarithromycin; Clavulanic Acids; Cross Infection; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Middle Aged | 1996 |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Time Factors; Virginiamycin | 1996 |
Failure to produce detectable antibodies to Legionella pneumophila by an immunocompetent adult.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Cefotaxime; Cephalosporins; Clarithromycin; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Erythromycin; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunocompetence; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Penicillins; Sputum; Travel; Turkey; United Kingdom | 2000 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Clinical presentations and outcome of severe acute respiratory syndrome in children.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Cefotaxime; Child; Child, Preschool; Clarithromycin; Disease Outbreaks; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hong Kong; Humans; Infant; Injections, Intravenous; Lung; Lymphopenia; Methylprednisolone; Oxygen Inhalation Therapy; Prednisolone; Prospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial | 2005 |
Development of pneumatoceles after viral infection.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Clarithromycin; Cysts; Humans; Lung Diseases; Male; Radiography; Staphylococcus aureus; Time Factors | 2006 |
Hemolytic uremic syndrome caused by Bordetella pertussis infection.
Topics: Acute Kidney Injury; Ampicillin; Anti-Bacterial Agents; Bordetella pertussis; Cefotaxime; Clarithromycin; Combined Modality Therapy; Hemolytic-Uremic Syndrome; Humans; Infant, Newborn; Male; Oxygen Inhalation Therapy; Treatment Outcome; Whooping Cough | 2010 |
Streptobacillus moniliformis bacteremia in a child: case report.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Clarithromycin; Female; Fusobacterium Infections; Humans; Infant; Streptobacillus | 2010 |
Moraxella catarrhalis AcrAB-OprM efflux pump contributes to antimicrobial resistance and is enhanced during cold shock response.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Cell Line; Clarithromycin; Cold-Shock Response; DNA, Bacterial; Drug Resistance, Bacterial; Epithelial Cells; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Moraxella catarrhalis; Mutation | 2015 |
Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital.
Topics: Bacterial Toxins; Bacterial Typing Techniques; Cefotaxime; Chromosomes, Bacterial; Clarithromycin; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterotoxins; Exotoxins; Humans; Interspersed Repetitive Sequences; Japan; Leukocidins; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Staphylococcal Infections; Superantigens; Tertiary Care Centers; Virulence Factors | 2015 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |